Erleva 100 mg Tablet
39,95$
31,34$
Erleva 100 mg Tablet is an effective anticancer medication primarily designed for the treatment of specific malignancies, including non-small cell lung cancer (NSCLC) and pancreatic cancer. This targeted therapy works by inhibiting the action of epidermal growth factor receptor (EGFR) tyrosine kinase, which plays a crucial role in cancer cell growth and proliferation. By blocking this pathway, Erleva helps to slow down or stop the spread of cancerous cells, offering hope for patients facing these challenging diagnoses. It is important to note that while Erleva can be beneficial, it may also come with side effects, such as skin rashes or gastrointestinal issues, which require careful management. Patients are advised to undergo regular monitoring and consult with their healthcare provider regarding any adverse reactions. Additionally, this medication is not suitable for everyone, so a thorough evaluation of medical history and potential drug interactions is essential before starting treatment. With its targeted approach, Erleva represents a significant advancement in cancer therapy, providing a vital option for those battling these aggressive diseases.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Erleva 100 mg tablet is primarily indicated for the treatment of non-small cell lung cancer, a prevalent form of lung cancer. This medication works by targeting specific cancer cells, helping to slow their growth and spread. Patients may experience symptoms such as persistent cough and chest pain, which can be alleviated with the effective use of Erleva 100 mg tablet. It is often prescribed when standard treatments have not been effective.
• In the management of pancreatic cancer, Erleva 100 mg tablet is utilized in combination with gemcitabine. This combination therapy enhances the effectiveness of treatment for patients diagnosed with this challenging condition. Symptoms of pancreatic cancer, including abdominal pain and jaundice, can be particularly distressing, and Erleva 100 mg tablet aims to improve patient outcomes. The coordinated approach with gemcitabine helps to address these symptoms and manage the disease more effectively.
• Erleva 100 mg tablet can be beneficial for patients with advanced cancer stages, particularly when other treatments have been unsuccessful. It is designed to target specific molecular pathways involved in cancer progression, which can lead to improved quality of life. Patients experiencing significant weight loss and fatigue due to their illness may find some relief with the introduction of Erleva 100 mg tablet into their treatment regimen. This medication is an important option in the oncology field for those facing difficult diagnoses.
• For patients diagnosed with non-small cell lung cancer or pancreatic cancer, Erleva 100 mg tablet serves as a crucial component of their treatment strategy. Its targeted action can help manage symptoms and improve overall health outcomes. By addressing the specific needs of cancer patients, Erleva 100 mg tablet supports both treatment efficacy and patient well-being. Oncologists often incorporate this medication into personalized treatment plans to optimize results.
Benefits
Erleva 100 mg Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Erleva 100 mg can help to slow the progression of cancer. Erleva Cancer Drug 100 mg may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Erleva Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
Like all medications, Erleva 100 mg Tablet can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Diarrhea
• Vomiting
• Gas
• Heartburn
• Mouth sores
• Constipation
• Headache
• Weight Loss
• Muscle or bone pain
• Anxiety
• Depression
• Hair loss
• Swelling of hands, feet, arms, lower legs or ankles
• Changes in nail and hair appearance
Common Side Effects
• Sudden chest pain
• Severe stomach pain
• Vision problems
• Heart attack
• Stroke
• Kidney or liver problems
• Rash
• Cough
• Peeling, blistering, cracked or dry skin
• Itching
• Tenderness
• Burning of the skin
• Fever
• Ingrown eyelash
• Pain in the neck, upper back or arms
• Difficult or slow speech
• Dizziness
• Weakness
• Dry mouth
• Dark urine
• Yellow or pale skin
How To Use
Take this medicine on an empty stomach, one hour before food or two hours after food. It is best to take exactly as prescribed by your doctor. Do not take more or less than directed. If you have trouble swallowing the Erleva 100 mg, you may crush the tablets and mix the powder with a small amount of water. Drink the mixture immediately. You should take the Erleva 100 mg Tablet at the same time each day to help you remember to take it. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose. Do not stop taking the Erleva Lung Cancer Medicine without first consulting your doctor.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Erleva 100 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Erleva 100 mg Tablet is safe for use in patients with mild to moderate kidney disease; no dose adjustment of Erleva 100 mg Tablet is recommended. The use of Erlotinib 100 mg Tablet Tablet is not recommended for severe kidney disease. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Erleva Cancer Drug 100 mg. Erleva 100 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Erleva 100 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Erleva 100 mg is safe for use in patients with mild to moderate liver disease; no dose adjustment of Erleva 100 mg Tablet is recommended. The use of Erlotinib 100 mg Tablet is not recommended for severe liver disease. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Erleva Cancer Drug 100 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Erleva 100 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Erleva 100 mg Tablet is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Erleva Tablet, such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved